Details of the Drug
General Information of Drug (ID: DMMWYFR)
Drug Name |
5-Phenylsulfanyl-2,4-Quinazolinediamine
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
5-Phenylsulfanyl-2,4-quinazolinediamine; 5-PHENYLSULFANYL-2,4-QUINAZOLINEDIAMINE; TCMDC-131943; 5-(phenylsulfanyl)quinazoline-2,4-diamine; 5-phenylsulfanylquinazoline-2,4-diamine; TQ3; AC1L9JD6; SCHEMBL2125192; CHEMBL100239; BDBM18045; GW997; ZINC5974663; 5-Phenylthioquinazoline-2,4-diamine; 2,4-Diamino-5-phenylthio-quinazoline; DB04163; 5-Phenylsulfanyl-quinazoline-2,4-diamine
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 268.34 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 2.9 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References